miRagen Therapeutics (NASDAQ: MGEN) is harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.
| Headquarters | Boulder, CO |
| Website | www.miragen.com |
| @miRagenRx | |
| Pipeline | Phase 1 clinical trials |
| Partners | Servier |